Immune tolerance regulation via tryptophan metabolism in autoimmune diseases, cancer and chronic inflammation. (Prof. Puccetti, Prof. Grohmann, Prof. Fallarino, Prof. Belladonna, Dott. Orabona, Dr. Gargaro);
Indoleamine 2,3-dioxygenase 2 (IDO2) expression and polymorphism in human cancer. (Prof. Puccetti, Prof. Grohmann, Prof. Fallarino, Prof. Belladonna, Dott. Orabona, Dott. Gargaro);
Molecular mechanisms of cytokines in tolerance and autoimmunity. (Prof. Puccetti, Prof. Grohmann, Prof. Fallarino, Prof. Belladonna, Dott. Orabona, Dr. Gargaro);
Role of metabolites and metabolite sensors in innovative immunotherapy approaches. (Prof. Puccetti, Prof. Grohmann, Prof. Fallarino, Prof. Belladonna, Dott. Orabona, Dott. Gargaro);
Dendritic cell subsets in immunoregulation in tumor and autoimmune and in rare diseases (Prof. Puccetti, Prof. Grohmann, Prof. Fallarino, Prof. Belladonna, Dr. Orabona, Dr. Gargaro);
Attenuated blood stage parasites as a new strategy for the development of vaccine against malaria disease (Prof. Spaccapelo);
Defining the rules of engagement: the study of collective behaviour to bridge knowledge gaps in An. gambiae mating (Prof. Spaccapelo and Dr. Peirce) ;
Investigating the mosquitoes microbiome for the identification of new symbionts to develop new strategy for malaria vector control (Prof. Spaccapelo and Dr. Peirce);
Role of metabolites in innovative immunotherapy approaches against malaria disease (Prof. Spaccapelo);
Study of the mechanisms of interaction between the host immune system and fungi as opportunistic pathogens (Prof. Zelante);
Setting of 3D human/mouse organoid model of infection (Prof. Zelante);
Probiotic use in oral mucositis (Prof. Zelante);
Investigating the biology of muscle precursor cells, muscle regeneration, muscle atrophy (including sarcopenia and cancer cachexia), muscular dystrophy, and rhabdomyosarcoma, with particular regards to RAGE (receptor for advanced glycation end-products) and the calcium-binding protein S100B (Prof. Sorci);
Investigating the intraperitoneal injection of microencapsulated Sertoli cells as a treatment to Duchenne muscular dystrophy (Prof. Sorci);
Investigating the molecular alterations induced by microgravity in human satellite cells (Prof. Sorci);
Investigating the efficacy of herbal extracts in counteracting muscle atrophy (Prof. Sorci);
Rare diseases involving Vitamin B6-dependent enzymes: molecular pathogenesis and development of new therapeutic strategies (Prof. Cellini);
Sertoli cell: an endocrine cellular system employed for treatment of type 1 and 2 diabetes mellitus, other autoimmune disorders, cell transplant and male infertility (Prof. Luca G., Dr. Calvitti M.);
Questo sito web utilizza cookie tecnici per migliorare l'esperienza di navigazione, senza tracciare alcun dato personale. In alcune pagine possono essere inclusi anche contenuti di terze parti (Cerca con Google, Google Maps) che raccolgono cookie di profilazione. Selezionando 'Accetto' si dà il consenso alla visualizzazione di contenuti di terze parti. Selezionando 'Nego' i contenuti di terze parti non verranno mostrati.